Preliminary findings suggest a drug used to treat    cryopyrin-associated periodic syndromes   disease might also reduce painful flare-up...

The U.S. FDA,  approved  Inlyta  (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded ...

In continuation of my up date on Exenatide... Amylin Pharmaceuticals, Inc. and Alkermes plc today announced that the U.S. Food and Drug ...

In continuation of my update on Dutasteride (Avodaart) New research suggests that Avodart , a drug used to treat an enlarged prostate ...

Psychedelic mushrooms (see above picture) may point to new ways to treat depression, suggest two small brain imaging studies that see...

In continuation of my update on regorafenib   The experimental cancer drug regorafenib appears to extend survival slightly in pati...

A new cocktail of two investigational drugs appears to have successfully cleared the hepatitis C virus in people who don't respond to...

In continuation of my update on Oxaliplatin  Adding oxaliplatin to a standard chemotherapy regimen boosts survival rates for pati...

Voraxaze receives FDA approval for treatment of toxic methotrexate levels : The U.S. Food and Drug Administration today approved Voraxaz...

In continuation of my update, artemisinin ... The most effective anti-malaria drug can now be produced inexpensively and in lar...

In continuation of my update on Dabigatran ... Researchers lead by Dr.Ken Uchino from the Cleveland Clinic in Ohio looked at sev...

Idenix Pharmaceuticals, Inc.  a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human ...

In continuation of my update on Levodopa .... The Phase 1 study (by Civitas Therapeutics, Inc) showed that CVT-301 achieved suffi...

In continuation of my update on Azithromycin.... Breakthrough in Treatment to Prevent Blindness | www.ucsf.edu

A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer's disease.  The drug, known as ...